Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combin...
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024
Project: SVDs-at-target
Updated at: 29-04-2024